Gene Therapy for Pompe Disease Effective in Mice, Poised for Human Trials (VIDEO)
Caption
Dwight Koeberl, M.D., Ph.D., describes a new gene therapy for Pompe disease Duke Health has developed and tested in mice. Researchers have FDA approval to launch a Phase 1 human trial and are working to secure funding.
Credit
Shawn Rocco/ Duke Health
Usage Restrictions
Please credit Shawn Rocco/ Duke Health
License
Licensed content